Brief: Aptevo Therapeutics Inc- Preliminary Data Observed To Date From Phase 1B Expansion Trial Evaluating APVO436 Includes One Complete Remission
23/11/2021 13:47
Nov 23 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC- PRELIMINARY DATA OBSERVED TO DATE
FROM
PHASE 1B EXPANSION TRIAL EVALUATING APVO436 INCLUDES ONE
COMPLETE REMISSION
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary